Can lactic acid inhibit the development of type 2 diabetes?

In a new research project with the support of Arla Food for Health, Associate Professor Esben Søndergaard from Aarhus University is investigating whether the consumption of lactic acid inhibits the risk of developing type 2 diabetes in overweight people.

The project is a collaboration between Esben Søndergaard and the University of Copenhagen, the Steno Diabetes Center Aarhus, Aarhus University Hospital and the Mayo Clinic, USA. Photo: Marie Agergaard Mikkelsen

In a new research project, which Arla Food for Health is supporting with DKK 4.9 million, Esben Søndergaard from the Department of Clinical Medicine is investigating whether overweight people with insulin resistance find it easier to convert sugar and fat if they consume lactic acid. His hypothesis is that the addition of lactic acid to a meal improves the handling of nutrients in people with overweight and insulin resistance, and that this reduces the risk of developing type 2 diabetes.

The grant from Arla Food for Health enables Esben Søndergaard to carry out clinical trials and PET scans, among other things, which can determine the absorption of fat from meals in the individual organs. The research project has the potential to contribute to the development of dietary advice and treatment of people at risk of developing type 2 diabetes. Esben Søndergaard also works as a clinician and associate professor at the Steno Diabetes Center Aarhus.

Contact

Associate Professor & PhD Esben Søndergaard
Aarhus University, Department of Clinical Medicine and
Steno Diabetes Center Aarhus
Mobile: (+45) 2873 0943
Email: Esben.sondergaard@clin.au.dk